Actively Recruiting

Phase 3
Age: 3Years +
All Genders
NCT06747507

Ndovu RCT: Investing the Optimal Management of Dolutegravir Resistance

Led by University of Nairobi · Updated on 2025-09-11

392

Participants Needed

9

Research Sites

95 weeks

Total Duration

On this page

Sponsors

U

University of Nairobi

Lead Sponsor

I

Instituto Nacional de Saúde, Mozambique

Collaborating Sponsor

AI-Summary

What this Trial Is About

This clinical trial will address the gap in published data on the effect of dolutegravir (DTG)-associated drug-resistant mutations on viral suppression among people remaining on DTG-based antiretroviral therapy. It will also address the gap in the optimal management strategy for this population.

CONDITIONS

Official Title

Ndovu RCT: Investing the Optimal Management of Dolutegravir Resistance

Who Can Participate

Age: 3Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Enrolled in the Ndovu cohort study
  • Able and willing to understand and comply with the protocol requirements, instructions and restrictions
  • Able and willing to provide informed consent for the nested clinical trial (assent as appropriate and legal guardian consent if < 18 years)
  • Age ≥ 3 years
  • Most recent HIV-1 RNA ≥ 200 copies/mL
  • At least one major DTG-associated DRM (substitution at codon 66K, 92Q, 118R, 138K/A/T, 140S/A/C, 148H/R/K, 155H or 263K)
Not Eligible

You will not qualify if you...

  • Pregnant or breastfeeding
  • Using any concomitant therapy disallowed as per the reference safety information and product labelling for the study drugs
  • WHO stage 3 or 4 opportunistic infection which would prevent randomisation to either arm (e.g. due to drug interactions or significant liver or renal injury) within 4 weeks prior to RCT screening
  • Investigator opinion that the potential participant should discontinue DTG immediately for clinical reasons
  • Investigator opinion that the potential participant should not switch to DRV/r for clinical reasons

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 9 locations

1

Jaramogi Oginga Odinga Teaching and Referral Hospital

Kisumu, Kenya

Actively Recruiting

2

Bomu Hospital

Mombasa, Kenya

Not Yet Recruiting

3

Kenyatta National Hospital

Nairobi, Kenya, 00100

Actively Recruiting

4

Butha-Buthe District Hospital

Butha-Buthe, Lesotho

Not Yet Recruiting

5

Mokhotlong District Hospital

Mokhotlong, Lesotho

Not Yet Recruiting

6

CS Ponta Gea

Beira, Sofala, Mozambique

Not Yet Recruiting

7

CS Machava II

Maputo, Mozambique

Not Yet Recruiting

8

CS Ndlavela

Maputo, Mozambique

Not Yet Recruiting

9

MUHAS Clinical Trial Unit

Dar es Salaam, Tanzania

Not Yet Recruiting

Loading map...

Research Team

J

Joseph Nkuranga, MBChB, MSc

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

TREATMENT

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here